[The results of research on the antioxidant emoksipin in clinical eye diseases].
Emoxipin, a new lipid peroxidation inhibitor, has been used in the treatment of various ophthalmic diseases. The drug is characterized by a retinal-protective and an additional fibrinolytic effects; it has been effectively used to preserve the visual function in glaucoma, to treat intraocular hemorrhages and retinal injuries with physical, chemical, or bacterial factors. A manifest effect has been observed in 87% of 106 patients (118 eyes) with various ocular abnormalities. Emoxipin is recommended for the treatment of a variety of ocular diseases.
Egorov
E A
EA
Shvedova
A A
AA
Obraztsova
I A
IA
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000975:Antioxidants / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005123:Eye; D005128:Eye Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007267:Injections / Q000379:methods; D008297:Male; D008875:Middle Aged; D010847:Picolines / Q000009:adverse effects / Q000627:therapeutic use*
D000975:Antioxidants; D010847:Picolines; C009820:6-methyl-2-ethyl-3-hydroxypyridine
Rezul'taty issledovaniia antioksidanta émoksipina v klinike glaznykh bolezneĭ.